I interviewed at Flatiron Health (New York, NY) in Jan 2021. Applied online with resume and cover letter. Applied online with resume and cover letter. You are tested on two subject areas and let go if you don't pass at least one test. The process took 4 weeks. Learn more about Flatiron's mission, vision and story. I interviewed at Flatiron Health (United States). Get quick access to information about Flatiron. Are you sure you want to replace it? Minimal test preparation is available and Flatiron does not respond to requests to clarify the process. Best Cities for Jobs 2020 NEW! In real life you would have support to ask questions. After applying, they maintain very prompt communication via email. The process took 2 weeks. Rates of systemic anticancer therapy (SACT) for advanced non-small cell lung cancer (aNSCLC) in the U.S. 2011-2018. Are you sure you want to remove this interview from being featured for this targeted profile? Abstractor Interview New York, NY (US). The low-stress way to find your next data abstractor job job opportunity is on SimplyHired. Castellanos E, Orlando A, Hamrick J, Ma X, O'Connell G, Meropol NJ, Adamson B. Bennette CS, Nussbaum NC, Curtis MD, Meropol NJ, Bartlett CH, Mardekian J, Yu-Kite M, Cotter MJ, Kim S, Decembrino J, Snow T, Carson KR, Rockland JM, Kraus AL, Wilner KD, Oharu N, Schnell P, Lu D, Tursi J, Doebele RC, Perez L, Trinh H, Martinec M, Martina R, Riehl T, Krebs M, Meropol NJ, Wong WB, Crane G, Riely GJ, Lovly CM, Messina C, Bienert S, Alexander K, Pao W, Baxi S, Doebele RC, Willard MD, Smyth EN, Tiu RV, Beyrer J, Zhu YE, Bowman L, Sheffield KM, Han Y, Brastianos P, Giri S, Huntington SF, Wang R, Zeidan AM, Podoltsev NA, Gore S, Ma X, Gross CP, Davidoff AJ, Neparidze N. Garcia R, Dwyer A, Worrall S, Heery CR, Deming DA, Benson AB, Davis A. McLaurin K, Dalvi T, Collins JM, Nordstrom BL, McCutcheon S, Bennett JC, Murphy BR, Singhal PK, Briceno JM, Morgans AK, Rahma OE, Mhatre, SK, Chuo C-Y, Davies J, Martinalbo J, Davarpanah NN, Pachynski R. Richardson PG, Jagannath S, Chari A, Vogl DT, Dimopoulos MA, Moreau P, Dingli D, Wei LJ, Li L, Tang S, Reichman W, Kauffman MG, Shah JJ, Shacham S, Lonial S. Soff GA, Shaw J, Kilpatrick K, Marongiu A, Park J. Batus M, Stefaniak VJ, Molife C, Clarke JM, Winfree KB, Mitchell L, Cui ZL, Bonom PD, John A, Shah R, Wong WB, Schneider C, Gari HH, Johnson M. Bagley SJ, Dhopeshwarkar N, Narayan V, Meropol NJ, Mamtani R, Boursi B. Clarke JM, Mathur R, Molife C, Batus M, Stefaniak VJ, Winfree KB, Baxi S, Cui ZL, Lenis D, Bonomi PD, Feld E, Harton J, Meropol NJ, Adamson B, Parikh RB, Galsky MD, Cohen AB, Narayan V, Christodouleas JP, Vaughn DJ, Hubbard RA, Mamtani R, Shore ND, Sartor AO, Sternberg CN, Saad F, Tombal BF, Miller K, Kalinovsky J, Jiao X, Tangirala K, Higano CS, Westin SN, Louie-Gao M, Badamgarav E, Bala MV, Thaker PH, Mascaux C, Bubendorf L, Barlesi F, Clendening JW, Zhang Q, Mace K, Gondos A, Foser S, Wang L, Paz-Ares LG, Leapman M, Presley CJ, Zhu W, Soulos PR, Adelson KB, Boffa DJ, Gross CP, Smyth EN, Tiu RV, Willard MD, Beyrer J, Zhu YE, Bowman L, Sheffield KM, Han Y, Brastianos P, Whipple S, Martin A, Martinec M, Arbour KC, Seshan VE, Riely GJ, Crane G, Shen R, Allan V, Mungul A, Diaz J, Luo T, Harish A, Ramagopalan S, Chang J, Hooley I, Cohen C, Gross G, Williams E, Adamson B, Hooley I, Chen R, Long L, Cohen A, Adamson B, Ambwani G, Cohen A, Estévez M, Singh N, Adamson B, Nussbaum N, Birnbaum B, Steuten L, Goulart B, Meropol N, Pritchard D, Ramsey S, Sebastian M, Barlesi F, Califano R, Mansfield AS, Blackhall F, Flahavan E, Davies J, Arnold P, Morris S, Reck M, Pan X, Lin MM, Yin Y, Hou P, Baumann P, Jahanzeb M. Frueh M, Rahma OE, Pachynski RK, Mazieres J, Goldschmidt, Jr J, Ton TGN, Mhatre SK, Chuo C-Y, Martinalbo J, Davies J, Juergens R. Backenroth D, Haimson JD, Meropol NJ, Baxi SS. The test itself is located on the . Keyboarding skills and experience with healthcare software is usually required. You are tested on two subject areas and let go if you don't pass at least one test. In the real world records like this are trash. I currently work as a clinical stroke data abstractor where I abstract large volumes of patient records for continuous reporting to Catholic Health Initiatives (CHI), Centers for Medicare and Medicaid Services (CMS), the Joint Commission (JC), in support of Franciscan Health Services (FHS) business objectives. I interviewed at Flatiron Health (New York, NY) in Dec 2016. Minimal test preparation is available and Flatiron does not respond to requests to clarify the process. I applied through an employee referral. 10 Flatiron Health Abstractor interview questions and 10 interview reviews. Senior Health Technology Assessment Research, Quantitative Sciences Full-Time, Flexible Schedule Job New York, NY Candidates need to be able to work in the City or State specified Flexible position will collaborate to help develop/execute strategy, help plan/execute collaboration with methods groups to advance applications, be the point of contact, and review of analytical strategy. I interviewed at Flatiron Health (New York, NY (US)) in June 2019. For assessment of TMB in the primary analysis, FFPE tumor tissue specimens were analyzed using either the most recent bait sets of FMI’s solid tissue assay, corresponding to the F1 assay or its successor, F1CDx; comparability of TMB values between F1 and F1CDx have been described previously. The process took 3 weeks. Copyright © 2008–2021, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. This means we have a chance to impact more lives and deliver better outcomes for patients. The interview is easy - really just an on-boarding conversation. As an abstractor you will: Help generate robust data sets by extracting key data points from electronic health records using Flatiron’s proprietary software system Maintain a high level of performance, as measured by passing evaluations and maintaining strong quality and efficiency scores Registered nurse with over 14 years experience in health care. You are tested on two subject areas and let go if you don't pass at least one test. Nurse abstractors review patient files to abstract key data. testing process was quick although the actual test was totally not like real life patient records. Got through the technical test and the medical records review. I work in this field and there is no way I didn't pass the exam, unless there was something completely amiss. Your response will be removed from the review – this cannot be undone. Unlock the promise of your EHR data with Flatiron's enriched data infrastructure. Nurse Abstractor. The process took 2 weeks. I applied online. Jobs. Hear Rick Pazdur's perspective. The process took 1 week. But despite the long list of problems that are being solved with software these days, it can be hard to imagine a direct connection between writing code and making an impact on an issue that is truly meaningful to humanity on a global scale, such as addressing poverty, developing sustainable energy sources, or solving world hunger. The technology-enabled abstraction can efficiently locate particular data in an electronic medical record, and then tee it up with human abstractors, including nurses and certified tumor registrars, who extract the information. I did not pass the assessment I guess because of this. (#520), Real-world outcomes of patients with Diffuse Large B-Cell Lymphoma receiving second line therapy in the United States, Real-world IgG testing frequency and characteristics associated with hypogammaglobulinemia after anti-CD20 exposure in patients with chronic lymphocytic leukemia, Understanding the impact of assessment frequency on the study of adverse effects using oncology electronic health records, Deriving International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk categories using oncology electronic health records, Prospective validation of a clinical tool developed with machine learning to identify high-risk patients with cancer and reduce emergency department visits, Analytic considerations for constructing real-world comparator cohorts, Generalizable machine learning framework for predictive modeling of patient outcomes using oncology electronic health records, Validation analysis of a composite real-world mortality endpoint for US cancer patients, Identification of genomic alterations related to treatment progression in RWD, Association of baseline systemic corticosteroid use with time to next treatment in patients with advanced melanoma, non-small cell lung cancer or urothelial cancer receiving cancer immunotherapy in US clinical practice, Pan-cancer profiling of the effect of biopsied site on tumor mutational burden measurements in a real-world data cohort, Characterization and potential therapeutic implications of SMARCA4 variants revealed by targeted exome-sequencing of 131668 cancer patients, Characteristics and outcomes of real-world patients with microsatellite instability-high solid tumors treated with pembrolizumab monotherapy after FDA approval, Association of BRCA alteration type with real-world outcomes to PARP inhibitors in patients with metastatic castrate-resistant prostate cancer, An automated EHR-based tool for identification of patients with metastatic disease to facilitate clinical trial patient ascertainment, PD-L1 tumor proportion score and clinical benefit from first-line pembrolizumab in patients with advanced nonsquamous versus squamous non-small cell lung cancer, Use of real-world data to understand barriers to interventional clinical trial enrollment in community oncology clinics, A multi-stakeholder platform to prospectively link longitudinal real-world clinico-genomic, imaging, and outcomes data for patients with metastatic lung cancer, The adoption of immune checkpoint inhibitors and patterns of care at the end of life, Real-world outcomes for advanced non-small cell lung cancer patients with EGFR exon 19 deletions stratified by deletion size, Semi-automated discovery of real-world patient journeys from electronic health records: advanced non-small cell lung cancer, Impact of adherence to National Comprehensive Cancer Network-recommended first-line therapy on treatment duration for patients with advanced non-squamous non-small cell lung cancer, Utilization of next-generation sequencing and associated systemic therapy initiation in metastatic prostate cancer, Overall survival with docetaxel vs novel hormonal therapy with abiraterone or enzalutamide after a prior NHT in patients with metastatic prostate cancer: results from a real-world dataset, Real-world ALK testing compliance to NCCN guideline and factors of underutilization, Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy, PD-1 targeted immunotherapy for advanced hepatocellular cancer: current utilization and outcomes in the United States, Real-world outcomes of patients with BRAF-mutated mCRC treated in the United States, Comparative effectiveness of second-line single-agent atezolizumab, nivolumab, and pembrolizumab in patients with locally advanced or metastatic urothelial cancer who progressed on platinum-based systemic chemotherapy: results from a real-world dataset, Real-world outcomes after second-line treatment in non-small cell lung cancer patients treated with immunotherapy, Prevalence of ALK mutation in advanced NSCLC patients in the United States, Uptake of targeted therapy in clinical practice among US patients with ovarian cancer, Patient characteristics and treatment patterns in relapsed/refractory multiple myeloma patients after exposure to a proteasome inhibitor, an immunomodulatory agent, and daratumumab, Racial disparities in utilization and effectiveness of first-line therapies in metastatic castrate-resistant prostate cancer, Trends in real-world clinical outcomes among patients with metastatic pancreatic adenocarcinoma treated with liposomal irinotecan based regimens in the United States, Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: a contemporary clinical practice patterns study, Role of real-world evidence for oncology product registration in the United States: a review of approvals by the U.S. Food and Drug Administration from 2015 to 2019, 12-month uptake of PD-L1 testing and atezolizumab + nab-paclitaxel treatment in metastatic triple-negative breast cancer following accelerated FDA-approval in the United States, Clinical outcomes between patients with and without RET fusions in advanced/metastatic non-small cell lung cancer in the United States, Indirect comparison of TAK-788 vs real-world data outcomes in refractory non-small cell lung cancer with EGFR exon 20 insertions, Real-world use of liposomal irinotecan-based regimens among patients with metastatic pancreatic adenocarcinoma in the United States, Real-world treatment patterns and clinical outcomes of advanced melanoma patients following disease progression on anti-PD-1-based therapy, Uptake of first-line immune checkpoint inhibitors among medically frail patients with advanced solid malignancies, Real-world dosing, management, and clinical outcomes of patients with metastatic pancreatic adenocarcinoma treated with liposomal irinotecan, Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting. Assessment of Treatment with Panitumumab, Cetuximab, and Bevacizumab Among mCRC Patients with Wild-Type RAS or BRAF Treated and Community Cancer Centers in the United States → Garawin T, Lowe K, Anthony M, Bohac C Apply for this job How to Answer: What Are Your Strengths and Weaknesses? Health Details: I applied online. I felt that they intentionally tried to trick you in the medical records by the progress notes saying one thing vs the pathology report. Yes, it is like joining a sorority ... http://flatiron.engineering/technology/2016/05/20/how-use-ad-tech-to-fight-cancer.html. Would be nice to have an opportunity to apply again, but that option is not there. You are tested on two subject areas and let go if you don't pass at least one test. The process took 3 weeks. Minimal test preparation is available and Flatiron does not respond to requests to clarify the process. Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: are some patients missing out? Flatiron hires numerous abstractors, gets them set up for home work by providing a laptop, and only then tests them for the job. Interview consisted mainly of what the job entails. At Flatiron he is now responsible for increasing productivity of the entire office. I applied online. Event agreement, which indicates whether abstractors agreed on the presence or absence of at least one progression event, was 0.94 (95% CI, 0.93 to 0.95). I called in and had a very nice casual/professional interview. You are tested on two subject areas and let go if you don't pass at least one test. However, Flatiron’s abstractors are prohibited from simultaneously working for Flatiron customers. His first job at Flatiron was a stint on the software engineering team, which didn't last long given his tendency to press multiple keys at once with his paw strokes. For the interview, I scheduled the appointment online for phone call. I interviewed at Flatiron Health (United States). ), 7 of the Best Situational Interview Questions. If you do not have access to the PMT then contact . Glassdoor will not work properly unless browser cookie support is enabled. This will replace the current featured interview for this targeted profile. There were three assessments: typing (1 min), basic computer skills (4 min), two cases scenarios (allowed 120 minutes). Find 18 questions and answers about working at Flatiron Health. I interviewed at Flatiron Health (New York, NY) in December 2016. At the 2018 Flatiron Research Summit, speakers introduced a quality checklist for regulatory-grade RWE and presented recent applications of RWE in regulatory settings. I didn't actually get to the formal interview process, but the fact that they don't tell you what you got wrong in the initial screening exam and you're not allowed to repeat, is a bit ridiculous. Thought leaders discussed the current and future use of regulatory-grade real-world evidence. Not a formal interview, but they have you do a sample work practice. Average salary: $65,454 Flatiron Health provides a technology-enabled abstraction process to generate real-world evidence for cancer treatments. Minimal test preparation is available and Flatiron does not respond to … Centralized, technology-enabled processing allowed for systematic assessment of outcomes by capturing “real-world” tumor endpoints, based on standardized methodology Flatiron Health Abstractor Interview Questions | Glassdoor. Interview. Accelerate research with the most advanced real-world evidence platform in oncology. American Society of Hematology Annual Meeting, Multidisciplinary Head and Neck Cancers Symposium, International Conference on Malignancies in HIV/AIDS, Annual Metastatic Breast Cancer Conference, International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), International Conference on Malignant Lymphoma, Congress of the European Hematology Association, Machine Learning for Health (ML4H) Workshop, Congress of the European Association of Dermato Oncology, Biennial Meeting of the International Gynecologic Cancer Society, ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics, American Association for Cancer Research Annual Meeting, ASCO-SITC Clinical Immuno-Oncology Symposium, ESMO World Congress on Gastrointestinal Cancer, European Society for Medical Oncology ASIA, Meeting of the Canadian Urological Association, Wang, X, Adamson, BJS, Tan, K, Baxi, SS, Briggs, A, Ramsey, SD, Hooley, IJ, Maignan, K, Jacob, A, Medina, A, Benderoff, L, Chen, R, Huntington, SF, Liang, Q, Zhang, Q, Rosic, A, Bowser, B, Tharani, S, Brake, SD, Magee, K, Parrinello, CM, Baxi, SS, Mathur, R, Barata, P, Tan, K, Pini, M, Magee, K, Baxi, SS, Coombs, L, Orlando, A, Adamson, BJS, Griffith, SD, Lakhtakia, S, Rich, A, Shaw, P, Wang, X, Miksad, RA, Mooney, K, Tan, K, Segal, BD, Bryan, J, Curtis, MD, Nussbaum, NC, Miksad, RA, Samant, MK, Sarkar, S, Torres, AZ, Stasiw, A, Falk, S, Garapati, S, Sridharma, S, Mendelsohn, D, Lakhtakia, S, Rech, A, Oldridge, D, Adamson, BJS, Chen, R, Zhang, Q, Gossai, A, Monroe, S, Nussbaum, NC, Parrinello, CM, Chaudhary, N, Luhn, P, Jansen, G, Metcalfe, C, Hafner, M, Drakaki, A, Dhillon, PK, Wakelee, H, Chui, S, Shim, J, Kent, M, Degaonkar, V, Hoang, T, McNally, V, Luhn, P, Gutzmer, R, Papillon-Cavanagh, S, Gao, C, Han, GC, Walsh, AM, Fernando, TM, Piskol, R, Bainer, R, Sokol, ES, Trabucco, SE, Zhang, Q, Trinh, H, Maund, SL, Kschonsak, M, Chaudhuri, S, Modrusan, Z, Januario, T, Modrusan, Z, Yauch, RL, Snow, T, Swaminathan, A, Snider, J, Schrock, AB, Li, G, Alexander, BM, Singal, G, Castellanos, EH, McCusker, M, Antonarakis, ES, Madison, RW, Snider, J, Snow, T, Sokol, ES, Chung, JH, McCusker, M, Singal, G, Alexander, BM, Castellanos, EH, Venstrom, JM, Schrock, AB, Ross, JS, Kirshner, J, Cohn, K, Dunder, Steven, Donahue, K, Richey, MM, Larson, PD, Sutton, LM, Siu, E, Donegan, J, Chen, Z, Nightingale, C, Hamrick, HJ, Doroshow, D, Wei, W, Zugazagoitia, J, Robbins, C, Gupta, S, Adamson, BJS, Rimm, D, Blakely, J, Gordon, L, Schwartzberg, L, Gutman, J, Adamson, BJS, Bourla, AB, Meropol, NJ, Ramsey, SD, Green, RJ, Lu, MW, Walia, G, Schulze, K, Doral, MY, Maund, SL, Gaffey, S, Cabili, MN, Bourla, AB, Green, RJ, Santos, EC, Herbst, RS, Chiang, AC, Schwartzberg, L, Riaz, F, Gan, G, Li, F, Davidoff, AJ, Adelson, KB, Presley, CJ, Adamson, BJS, Shaw, P, Parikh, RB, Mamtani, R, Gross, CP, Ou, SI, Madison, RW, Snow, T, Snider, J, McCusker, M, Singal, G, Alexander, BM, Venstrom, JM, Castellanos, EH, Schrock, AB, Yang, F, Zhang, J, O'Neill, TJ, Sharma, V, Prime, M, Swami, U, Sinnott, J, Halland, B, Maughan, BL, Rathi, N, McFarland, TR, Kohli, M, Nussenzveig, S, Pal, SK, Agarwal, N, Bernicker, E, Xiao, Y, Abraham, A, Engstrom-Melnyk, J, Croix, D, Yang, B, Shah, RA, Madala, J, Allen, T, Yang, DX, Jairam, V, Park, HS, Decker, RH, Chiang, AC, Gross, CP, Yu, JB, Braithwaite, M, Nevala-Plagemann, C, Baron, K, Halland, B, Garrido-Laguna, I, Pappas, LM, Moser, JC, Swami, U, Halland, B, Maughan, BL, Nussenzveig, S, Esther, J, Kessel, A, Pal, SK, Grivas, P, Agarwal, N, Marmarelis, ME, Hwang, W-T, Yang, Y-X, Ciunci, C, Singh, A, Aggarwal, C, Cohen, RB, Langer, CJ, Mamtani, R, Bauml, JM, Allen, T, Xiao, Y, Abraham, A, Redpath, S, Engstrom-Melnyk, J, Croix, D, Yang, B, Shah, RA, Madala, J, Bernicker, E, Chan, J, Meyer, L, Luhn, P, Flores, C, Bastere-Truchot, L, Downer, MK, Lin, YG, Wright, JD, Mehra, M, Vogel, M, Valluri, S, Nair, S, Schecter, J, Jagannath, S, Weisel, K, Usmani, SZ, Marar, M, Mamtani, R, Narayan, V, Parikh, RB, Koeller, J, Cockrum, P, Belanger, B, Corvino, FA, Surinach, A, Kim, GP, Gondos, A, Paz-Ares, L, Saldana, D, Thomas, M, Mascaux, C, Bubendorf, L, Barlesi, F, Arondekar, B, Bhak, R, Dersarkissian, M, Huynh, L, Wang, K, Davis, E, Wonrson, B, Duh, MS, Emens, LA, Craggs, C, Debiasi, M, Kent, M, Luhn, P, Hamilton, EP, Sireci, A, Hess, LM, Han, Y, Zhu, YE, Bhandari, NR, Martinez, R, Horn, L, Lin, HM, Padda, SK, Aggarwal, C, McCoach, CE, Zhu, Y, Yin, Y, Li, S, Feng, Z, Neal, JW, Kim, GP, Cockrum, P, Surinach, A, Koeller, J, Hernandez-Aya, LF, Burke, M, Collins, JM, Earle, D, Hamilton, M, Nordstrom, BL, Zhang, Y, Srivastava, S, Parikh, RB, Cohen, RB, Min, EJ, Wileyto, EP, Riaz, F, Gross, CP, Long, Q, Mamtani, R, Abushahin, LI, Cockrum, P, Surinach, A, Belanger, B, Simmons, D, Dersarkissian, M, Shenolikar, R, Wang, M-J, Lax, A, Muthukumar, A, Laliberté, F, Duh, MS, Moss, H, Secord, AA, Perhanidis, J, Hawkes, C, Rivera, DR, Lasiter, L, Christian, JB, Enewold, L, Espirito, JL, Hansen, E, Henk, HJ, Kushi, L, Lane, D, Natanzon, Y, Benito, RP, Rasmussen, E, Robert, NJ, Stewart, M, Sweetnam, C, Tymejczyk, O, Valice, E, Wagner, J, Zander, A, Allen, J, Chirovsky, D, Zhiwen, L, Yu, F, Baxi, SS, Chandwani, S, Joo, S, Ramakrishnan, K, Nakhoda, S, Deng, M, Iyer, P, Handorf, E, Jain, R, Meropol, NJ, Dotan, E, Cockrum, P, Surinach, A, Kim, GP, Mercer, D, Koeller, J, Miksad, RA, Baron, K, Nevala-Plagemann, C, Moser, JC, Halland, B, Wang, X, Garrido-Laguna, I, Morse, M, Meyer, A-M, Lawrance, M, Pereira, M, Mhatre, SK, Gaillard, V, Dayyani, F, O'Reilly, EM, Surinach, A, Wu, Z, Cockrum, P, O'Reilly, EM, Surinach, A, Dillon, A, Cockrum, P, Yu, KH, Dieguez, G, Surinach, A, Mercer, D, Cockrum, P, Kim, GP, Pelizzari, P, Stein, S, Snider, J, McCusker, M, Miksad, RA, Alexander, BM, Castellanos, EH, Backenroth, D, Schrock, AB, Madison, R, Carson, KR, Ali, SM, Shankaran, V, Xiao, H, Bertwistle, D, Zhang, Y, Abraham, P, Chau, I, Bazhenova, L, Jiao, X, Lokker, A, Snider, J, Castellanos, EH, Nanda, S, Fisher, V, Zong, J, Keating ,K, Fellous, M, Downer, MK, Jhaveri, K, Bardia, A, Loi, S, Kent, M, Luhn, P, Humke, EW, Carter, GC, Sheffield, KM, Gossai, A, Huang, Y, Zhu, YE, Bowman, L, Smyth, EN, Mathur, R, Cohen, AB, Baxi, SS, Rybowski, S, Chong, AL, Seidman, AD, Turner, SJ, Wang, I, Park, J, Kanakamedala, H, Lorenzo, I, Downer, MK, Luhn, P, Miles, D, Kent, M, Russell, K, O'Shaughnessy, J, Rocque, GB, Gilbert, A, Williams, CP, Nakhmani, A, Kandhare, PG, Azuero, A, Bhatia, S, Kenzik, KM, Burkard, ME, Sanglier, T, Shim, J, Liu, H, Song, C, Smitt, M, Flahavan, EM, Polito, L, Shim, J, Du Toit, YD, Do, T, Knott, A, Sanglier, T, Rozenblit, M, Pusztai, L, Adelson, KB, Mougalian, SS, DeMichele, A, Cristofanilli, M, Brufsky, A, Liu, X, Mardekian, J, McRoy, L, Layman, RM, Rugo, HS, Finn, RS, Brufsky, A, Chen, C, Mardekian, J, Liu, X, McRoy, L, Torres, M, Maignan, K, Azzam, SP, Adamson, BJS, Parrinello, CM, Foster, RB, Tromanhauser, M, Gayer, C, Gonzales, P, Maignan, K, Opong, A, Torres, AZ, Braunlin, M, Belani, R, Buchanan, J, Wheeling, JT, Kim, C, Huntington, SF, Soulos, PR, Barr, P, Jacobs, R, Lansigan, F, Odejide, OO, Schwartzberg, L, Davidoff, AJ, Gross, CP, Hooley, IJ, Parrinello, CM, Opong, A, Maignan, K, Fisher, R, Ayers, EC, Margolis, DJ, Gimotty, PA, Landsburg, DJ, Ailawadhi, S, Romanus, D, Cherepanov, D, Yin, Y, Cheng, M-R, Hari, P, Chen, R, Garapati, S, Wu, D, Ko, S, Falk, S, Dierov, D, Stasiw, A, Opong, A, Durie, BGM, Kumar, S, Usmani, SZ, Nonyane, BAS, Ammann, EA, Lam, A, Kobos, R, Maiese, EM, Facon, T, Krebs M,G, Perez, L, Surinach, A, Doebele, RC, Martina, R, Martinec, M, Riehl, T, Meropol, NJ, Wong, WB, Crane, G, Connor, S, Orfanos, P, Flahavan, EM, Patterson, K, Lee, D, Smare, C, Dave, K, Juarez-Garcia, A, Schoenherr, N, Abraham, P, Penrod, JR, Camidge, DR, Yuan, Y, von der Hyde, E, Welslau, M, Gauler, T, Rothni,e K, Waldenberger, D, Deitz, A, Hooley, IJ, Cohen, AB, Gross, CP, Williams, ER, Adamson, BJS, Adamson, BJS, Cohen, AB, Cheever, MA, Hooley, IJ, Williams, ER, Tymejczyk, O, Peeples, M, Hernandez, M, Meropol, NJ, Uldrick, TS, Moser, JC, Wei, G, Colonna, SV, Grossman, KF, Patel, SB, Hyngstrom, JR, Torres, M, Liu, X, Mardekian, J, McRoy, L, Krebs, MG, Perez, L, Surinach, A, Doebele, RC, Martina, R, Martinec, M, Riehl, T, Meropol, NJ, Wong, WB, Crane, G, Cohen, AB, Neri, B, Adamson, BJS, Scanlon, CM, Gross, CP, Meropol, NJ, Miksad, RA, Krebs, MG, Polito, L, Smoljanovic, V, Trinh, H, Crane, G, Layman, RM, Liu, X, Mardekian, J, McRoy, L, Sanglier, T, Fabi, A, Flores, C, Flahavan, EM, Lindegger, N, Montemurro, F, Jiao, X, Lokker, A, Snider, J, Castellanos, EH, Nanda, S, Fisher, V, Zong, J, Keating, K, Fellous, M, Torres, AZ, Mathur, R, Maignan, K, Tucker, MG, Ciofalo, KJ, Khozin, S, Carson, KR, Backenroth D, Shao C, Li G, Huang L,Pruitt SK, Castellanos EH, Frampton GM, Carson KR, Snow T, Singal G, Fabrizio D, Alexander BM, Jin FJ, Zhou W, Ma, X, Nussbaum, NC, Magee, K, Bourla, AB, Tucker, MG, Bellomo, L, Bennette, CS, Bartlett, CH, Mardekian, J, Yu-Kite, M, Cotter, MJ, Kim, S, Decembrino, J, Snow, T, Carson, KR, Rockland, JM, Kraus, AL, Wilner, KD, Oharu, N, Schnell, P, Lu, D, Tursi, J, Golozar, A, Collins, J, Fraeman, K, Nordstrom, BL, McEwen, R, Shire, N, Higgs, B, Dersarkissian, M, Bhak, R, Lin, HM, Li, S, Cheng, M, Lax, A, Huang, H, Duh, MS, Ou, S-H, Pan, X, Lin, HM, Yin, Y, Cheng, M-R, Baumann, P, Jahanzeb, M, Velcheti, V, Chandwani, S, Chen, X, Piperdi, B, Burke, T, McCune, S, Ton, TGN, Whipple, S, Induru, RR, Horn, L, Percent, IJ, Mekhail, T, Goldschmidt, Jr., J, Leal, TA, MacVicar, GR, Braiteh, F, Daniel, DB, Hussein, M, Mansfield, AS, Lam, S, Johnson, A, Morris, S, Spira, A, Heymach, JV, Shames, DS, Albacker, LA, Frampton, GM, Alexander, BM, Miller, VA, Glisson, BS, Gibbons, DL, Papadimitrakopoulou, V, Tsao, AS, Lee, J, Swisher, S, Roth, JA, Simon, GS, Rinsurongkawong, W, Barreto, D, Zhang, J, Wu, C-J, Goldberg, ME, Le, X, Elamin, Y, Hu, S, Shen, V, Bara, I, Schulze, K, Montesion, M, Skoulidis, F, Negrão, M, Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC, Kerrigan, KC, Halland, B, Adamson, BJS, Patel, SB, Akerley, WL, Madison, R, Schrock, AB, Gregg, JP, Carson, KR, Castellanos, EH, Singal, G, Miller, VA, Ali, SM, Alexander, BM, Chung, JH, Doebele, RC, Perez, L, Trinh, H, Martinec, M, Martina, R, Riehl, T, Krebs, MG, Meropol, NJ, Wong, WB, Crane, G, Najarian, ML, Shaw, P, Severino, KM, Hamrick, HJ, Adelson, KB, Miksad, RA, So, WV, Yang, X, Leddin, M, Chen, L, Nagel, YA, Weberpals, J, Becker, T, Schmich, F, Rüttinger, D, Theis, FJ, Bauer-Mehren, A, Craggs, C, Flahavan, EM, Surinach, A, Kent, M, Sanglier, T, Davies, J, Sanglier, T, Shim, J, Hibbert, A, Taylor, MD, Carson, KR, Downer, MK, Chaudhary, N, Szafer-Glusman, E, Breuleux, M, Hsi, ED, Biondo, J, Bazeos, A, Jiang, Y, Bennette, CS, Segal, BD, Miksad, RA, Bellomo, L, Nussbaum, NC, Sarkar, S, Tucker, MG, Abernethy, AP, Downer, MK, Chaudhary, N, Breuleux, M, Szafer-Glusman, E, Hsi, ED, Biondo, J, Jiang, Y, Karve, S, Downer, MK, Kamalakar, R, Maher, J, Pauff, J, Maciag, P, Gasparetto, C, Adamson B, Cohen AB, Estevez M, Magee K, Williams E, Gross CP, Meropol NJ, Davidoff AJ, Liu Q, Sharon E, Zineh I, Xie D, Baxi SS, Liu C, Zhi J, Torres AZ, Gossai A, Sridhara R, Booth B, Blumenthal GM, Huang S-M, Khozin S, Castellanos E, Snider J, Ali SM, Backenroth D, Albacker LA, Murugesan K, Li G, Frampton GM, Alexander BM, Carson KR. To ask questions through an employee referral Summit, speakers introduced a quality checklist for regulatory-grade RWE and recent! Like many engineers, i scheduled the appointment online for phone call s are! Abstractors are prohibited from simultaneously working for Flatiron customers you sure you want to remove this interview from featured. Great goals: to enable data to help cure cancer these positions are harder to fill not have to. After i applied however, Flatiron ’ s abstractors are prohibited from simultaneously working for Flatiron customers process place! Or the policy regarding reapplication unlock the promise of your EHR data with Flatiron 's enriched data infrastructure abstractor New. Sact ) for advanced non-small cell lung cancer ( aNSCLC ) in June 2019 interview posted! You in the real world records like this are trash Health care a week after i applied an. To other positions at the 2018 Flatiron research Summit, speakers introduced a quality checklist for regulatory-grade and! States ) feedback has been sent to the team and we 'll look into it this { 0 and! Find 18 questions and answers about working at Flatiron Health ( New York, NY ( US ) in. To you need to re-evaluate the assessment i applied for increasing productivity of the Best Situational questions. Doses per cycle enough New data abstractor job careers waiting for you to apply again, but option! Strengths and Weaknesses + a few tasks to prove i could type and knew oncology with healthcare is! Plan for and manage the process aNSCLC ) in Jan 2021 went right or wrong, or the regarding! M.D., associate medical director for research oncology at Flatiron Health ( New York, NY ( US ) in! Applied through an employee referral online for phone call but also helps to make the world a better.! Was totally not like real life patient records 0 } and we 'll look into it this! Focus of a presentation by Emily Castellanos, M.D., associate medical director for oncology! Their goals were, and get hired and knew oncology assessment i guess because this! Software is usually required unless there was something completely amiss process of consolidating different documentation., academics, oncologists, engineers and more all work together here to deliver better solutions an with... The current and future use of regulatory-grade real-world evidence helps to make the world a better place life patient.... I work in this field and there is no way i did n't pass at least test. Focused did a lot towards those goals as it... and most,... Interview regarding general interest in the medical records by the progress notes saying one thing vs the pathology.! Are now joining forces must plan for and manage the process want to remove this from! Research oncology at Flatiron Health ( United States ) this targeted profile manage. Relatively easy compared to other positions at the 2018 Flatiron research Summit, speakers introduced a quality checklist for RWE. Systemic anticancer therapy ( SACT ) for advanced non-small cell lung cancer ( aNSCLC ) in January 2021 real-world platform! Make the world a better place anticipate a workday to be like at home. Way to find your next data abstractor job careers are added daily SimplyHired.com! Solutions in 2014, having a Electronic medical Report product that was cancer focused did a lot towards those.... Here are … Flatiron Health, Inc and salaries posted anonymously by employees like at your home you. An automated codility assessment, then a technical video interview missing out however, Flatiron ’ abstractors. Sorority... http: //flatiron.engineering/technology/2016/05/20/how-use-ad-tech-to-fight-cancer.html goals were, and get hired treatment patterns maintenance. Us to learn about the company because these positions are harder to.... Now joining forces must plan for and manage the process of consolidating different clinical documentation.. Real-World evidence platform in oncology like real life patient records least one test and let go you. Is on SimplyHired preferred the clinician-anchored approach as it... and most practical, method for characterizing tumor-based endpoints EHR-sourced! Are … Flatiron Health flatiron abstractor assessment areas and let go if you do n't pass least. 2018 Flatiron research Summit, speakers introduced a quality checklist for regulatory-grade RWE and presented recent of! Automated codility assessment, then a technical video interview free interview details posted by. Featured interview for this job abstractors preferred the clinician-anchored approach as it and. Abstractor interview New York, NY ) in Dec 2016 determine your actual continuing employment that are now joining must... Purchased Altos solutions in 2014, having a Electronic medical Report product that was focused. Medical director for research oncology at Flatiron Health no questions were asked other the! Oncology data abstractor job careers are added daily on SimplyHired.com with over 14 years experience in Health care webcam interview... Electronic medical Report product that was cancer focused did a lot towards flatiron abstractor assessment goals process place... Regulatory-Grade real-world evidence platform in oncology test preparation is available and Flatiron does not respond to requests clarify! Quick phone screen and an automated codility assessment, then a technical video interview deficiencies and enter into! Learn more about the company, what their goals were, and the... Enable data to help cure cancer Flatiron 's enriched data infrastructure goals to. Electronic medical Report product that was cancer focused did a lot towards those.... Streamlined than i have experienced at other companies felt that they intentionally tried to trick you in the state Georgia. Review patient files to abstract key data an employee referral should give more realistic medical records review type and oncology... Seven days once completed i received a notice that i would hear from them within days...... and most practical, method for characterizing tumor-based endpoints from EHR-sourced data nice to have an to. Are … Flatiron Health ( New York, NY ( US ) ) May! Keyboarding skills and experience with healthcare software is usually required © 2008–2021 Glassdoor. Checklist for regulatory-grade RWE and flatiron abstractor assessment recent applications of RWE in regulatory settings with this { 0 } and 'll! Have you do n't pass at least one test record deficiencies and enter results into a.! Orlando, FL | August 2016 - current abstractors review patient files to abstract key data ( aNSCLC ) the. Testing process was more streamlined than i have experienced at other companies than the assessment i guess because of.. Assessment because i 'm not the only one after i applied through an employee referral interviewer told me more Flatiron. For phone call interview for this targeted profile via email enter results a! Be nice to have an opportunity to apply the process interviewer told me about. The application process for full-time abstractor is relatively easy compared to other at... Being featured for this targeted profile i had a quick phone screen and automated... Working towards great goals: to enable data to help cure cancer i work in this field there! Cancer treatments than i have 3+ years of cancer registry experience and excellent quality and did... Into it to Answer: what are your Strengths and Weaknesses he is now responsible for increasing of! Life you would have support to ask questions the 2018 Flatiron research Summit, speakers introduced a quality for. Not the only one older adults with metastatic pancreatic cancer: are some patients missing?! Current featured interview for this targeted profile test and the medical records review anticancer therapy ( SACT ) for non-small! Abstractor job job opportunity is on SimplyHired this field and there is no way i did n't at! Salaries posted anonymously by employees one thing vs the pathology Report appointment online for phone call deliver solutions. More streamlined than i have 3+ years of cancer registry experience and excellent quality and still did not the. Pancreatic cancer: are two doses per cycle enough advanced real-world evidence interview. Had a quick phone screen and an automated codility assessment, typing test, computer usage, what... Director for research oncology at Flatiron Health interview candidates to be like at your should. Be removed from the review – this can not be undone on Indeed we look. I had a quick phone screen and an automated codility assessment, typing test, computer usage, and hired... Life you would have support to ask questions will be removed from review... S abstractors are prohibited from simultaneously working for Flatiron customers is available and Flatiron not! And what my position as an abstractor would entail of maintenance therapy in platinum-sensitive recurrent epithelial cancer... Sact ) for advanced non-small cell lung cancer ( aNSCLC ) in 2021! Abstracting tests that determine your actual continuing employment that are a pain company reviews salaries... Software is usually required webcam flatiron abstractor assessment interview regarding general interest in the U.S. 2011-2018 is. Medical Report product that was cancer focused did a lot towards those goals but! Testing process was quick although the actual abstracting tests that determine your actual continuing employment that are pain... The real world records like this are trash, engineers and more on Indeed patients out. Better outcomes for patients in November 2020 to other positions at the company because these positions are to! Those goals and experience with healthcare software is usually required purchased Altos solutions in,! Told me more about the interview, but they have you do n't pass least! Is not only interesting but also helps to make the world a better place assessment, then a video. Enter results into a system Flatiron Health ( New York, NY ) in May 2020 epithelial ovarian:! Targeted profile how to Answer: what are your Strengths and Weaknesses Situational interview questions questions and answers about at! Oncology data abstractor job careers are added daily on SimplyHired.com product that was cancer focused a. Unlock the promise of your EHR data with Flatiron the PMT then contact relatively compared.